Assessment of the prognostic value of baseline parenclitic indexes to differentiate between 6-month outcomes comparing standard care with targeted albumin therapy
REGRESSION
The result of multivariate Cox regression for the interaction of targeted albumin treatment with baseline parenclitic variables to predict 6-month survival showed that measures of global parenclitic network characteristics (i.e., diameter and mean shortest path length), WCC-CRP parenclitic deviation, baseline serum albumin, and white cell count significantly interacted with targeted albumin treatment to predict survival (see Supplementary Table S4, Supplementary Digital Content, Kaplan-Meier graph representing 6-month survival prediction of patients based on network shortest path length cutoff (Kaplan-Meier graph representing 6-month survival prediction of patients based on network diameter cutoff (Kaplan-Meier graph representing 6-month survival prediction of patients based on δ (WCC-CRP) cutoff (